Doctor pleads guilty as part of Aegerion drug misbranding probe
A pediatric cardiologist from Georgia has pleaded guilty to divulging information about his patients to Aegerion Pharmaceuticals in 2013, as the Cambridge-based company was looking for ways to boost sales of cholesterol drug Juxtapid by promoting it for off-label uses.
During a hearing on Wednesday in Boston federal court, Eduardo Montaña pleaded guilty to violating the Health Insurance Portability and Accountability Act, or HIPAA. According to a court filing, Montaña admitted that he provided…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Max Stendahl Source Type: news
More News: Cardiology | Cholesterol | Georgia Health | Health Insurance | Health Management | Heart | HIPAA | Insurance | Legislation | Pediatrics | Pharmaceuticals